Study of heart preservation in children needing a first transplant
Part of Heart & circulation clinical trials.
This study looks at how the heart muscle is kept healthy after donation and before transplant in children. It aims to improve transplant success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be under 18 years old (any age from birth to 17 years and 364 days)
- Waiting for their very first heart transplant
- Listed on the official waiting list for a donor heart
- Patient or their legal guardian must understand the study and sign a consent form
- Cannot have taken part in another research study within the past 30 days
- Must not have a failing Fontan circulation or have had a multiorgan transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well donor hearts work and how that affects outcomes after heart transplantation. It may help transplant teams choose and use donor hearts more effectively.
This early-phase study tests a cell treatment (Treg cells made from a child’s thymus tissue) to help prevent the body from rejecting a new heart. It may help reduce rejection risk, but it is experimental and involves added risks and follow-up.
This trial tests whether Thymoglobulin® is safe and how well it works in people getting their first heart transplant. It may help doctors fine-tune medicines used to prevent the body from rejecting the new heart.
This trial tests a new cooling method to safely transport donor hearts. It is for people receiving only a heart transplant (no other organs at the same time).
This trial studies whether belatacept, an anti-rejection medicine given by IV, can work for people receiving their first heart transplant. It aims to see if it prevents rejection safely for patients and whether it fits better than standard approaches for certain candidates.
This trial tests a special machine that preserves donor hearts for longer periods before transplant. It may help people waiting for a heart transplant who need a heart from a donor that may be older or has some heart risks.
Hear when a new Heart Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.